United States · FDA National Drug Code directory
ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42571-274_336d06cd-6aab-a167-e063-6294a90ad16d
- Product NDC
- 42571-274
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- ASPIRIN and Extended-Release DIPYRIDAMOLE
- Labeler
- Micro Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210816
- Source listing expiry
- 20261231
Source-listed ingredients
- ASPIRIN — 25 mg/1
- DIPYRIDAMOLE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42571-274-60) · 42571-274-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →